Prognostic markers of levosimendan treatment efficacy in severe congestive heart failure: a prospective multicentre study

被引：0
|
作者：
Bocchi, E
Guimaraes, G
Vilas-Boas, F
机构：
[1] Univ Sao Paulo, Sch Med, Inst Heart, InCor, Sao Paulo, Brazil
[2] Hosp Santa Izabel, Brazilian Soc Cardiol, GEIC, Salvador, BA, Brazil
来源：
EUROPEAN HEART JOURNAL | 2003年 / 24卷
关键词：
D O I：
10.1016/S0195-668X(03)95161-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：408 / 408
页数：1
相关论文
共 50 条
  • [21] Natriuretic peptides or psychometric tests? Prognostic markers in congestive heart failure
    Herrmann-Lingen, Christoph
    Pieske, Burkert
    HEART, 2008, 94 (05) : 545 - 546
  • [22] Measurement of neurohormones as prognostic markers for survival in patients with congestive heart failure
    Boomsma, F
    de Kam, P
    Geertsema, T
    van Veldhuisen, D
    JOURNAL OF HYPERTENSION, 2000, 18 : S110 - S110
  • [23] Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial
    Altenberger, Johann
    Parissis, John T.
    Costard-Jaeckle, Angelika
    Winter, Andreas
    Ebner, Christian
    Karavidas, Apostolos
    Sihorsch, Kurt
    Avgeropoulou, Ekaterini
    Weber, Thomas
    Dimopoulos, Lida
    Ulmer, Hanno
    Poelzl, Gerhard
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (08) : 898 - 906
  • [24] Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failure
    Poder, P
    Eha, J
    Sundberg, S
    Antila, S
    Heinpalu, M
    Loogna, I
    Planken, Ü
    Rantanen, S
    Lehtonen, L
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2003, 41 (08) : 365 - 373
  • [25] Efficacy of enalapril in the treatment of congestive heart failure in dogs
    Voros, K
    Vrabely, T
    Manczur, F
    Szatmari, V
    MAGYAR ALLATORVOSOK LAPJA, 1998, 120 (05) : 274 - 280
  • [26] Efficacy and safety of intravenous levosimendan in severe low-output heart failure
    Follath, F
    Cleland, JGF
    Scholtz, H
    Papp, JGY
    Peuhkurinen, K
    Harjola, VP
    Abdalla, M
    Lehtonen, LA
    CIRCULATION, 1999, 100 (18) : 646 - 646
  • [27] A prospective, randomized trial of BiPAP in severe acute congestive heart failure
    Levitt, MA
    JOURNAL OF EMERGENCY MEDICINE, 2001, 21 (04): : 363 - 369
  • [28] Pharmacokinetics of levosimendan in healthy volunteers and patients with congestive heart failure
    Sandell, EP
    Hayha, M
    Antila, S
    Heikkinen, P
    Ottoila, P
    Lehtonen, LA
    Pentikainen, PJ
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 : S57 - S62
  • [29] Myocardial efficiency during levosimendan infusion in congestive heart failure
    Ukkonen, H
    Saraste, M
    Akkila, J
    Knuuti, J
    Karanko, M
    Iida, H
    Lehikoinen, P
    Någren, K
    Lehtonen, L
    Voipio-Pulkki, LM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (05) : 522 - 531
  • [30] SAFETY AND EFFICACY OF EPOPROSTENOL IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE
    SUETA, CA
    GHEORGHIADE, M
    ADAMS, KF
    BOURGE, RC
    MURALI, S
    URETSKY, BF
    PRITZKER, MR
    MCGOON, MD
    BUTMAN, SM
    GROSSMAN, SH
    CROW, JW
    SHAFFER, CL
    THORN, MD
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (03): : A34 - A43
12345